APLS Stockholders Should Contact Robbins LLP for Information About the Class Action Involving Apellis Pharmaceuticals, Inc.
21 août 2023 13h31 HE
|
Robbins LLP
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action against Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) on behalf of persons or...
APLS Stock News: Investors with Significant Losses in Apellis Pharmaceuticals, Inc. Should Contact Robbins LLP About Recovery
14 août 2023 18h01 HE
|
Robbins LLP
SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action against Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) on behalf of persons or...
Apellis Pharmaceuticals, Inc. (APLS) Investor Alert: Robbins LLP Reminds Shareholders of Class Action Against Apellis Pharmaceuticals, Inc.
07 août 2023 20h24 HE
|
Robbins LLP
SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action against Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) on behalf of persons and...